[300 Pages Report] The endoscope detergents and disinfectants market is likely to secure a CAGR of 4.4% during the forecast period. The market is projected to be valued at US$ 687.7 Million in 2022 and is likely to be valued at US$ 1,108.2 Million by 2032.
| Report Attribute | Details |
|---|---|
| Endoscope Detergents and Disinfectants Market Value (2022) | US$ 687.7 Million |
| Endoscope Detergents and Disinfectants Market Anticipated Value (2032) | US$ 1,108.2 Million |
| Endoscope Detergents and Disinfectants Projected Growth Rate (2032) | 4.4% |
The adoption of endoscope detergents and disinfectant chemicals has been widely rising owing to their usage for various medical devices like endoscopes in recent years. They are gaining rapid traction in the global forum, as these solutions are preventing the growth of harmful bacteria and viruses and reducing the chances of acquiring diseases in the medical industry.
The demand for endoscope detergents and disinfectants is expected to increase in the coming years, as they can kill almost all types of vegetative non-spore-forming bacteria, fungi, viruses, and mycobacterium (TB) that appears on surgery tools.
Endoscope detergent and disinfectants also help to clean automation and various mechanical tools. Additionally, detergents and disinfectants are used before every procedure to make the device significantly contamination free. Therefore, it is anticipated that the endoscope detergents and disinfectants market is likely to witness significant growth during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Several factors are fueling the expansion of the endoscope detergent and disinfectant market; they can be summarized as follows:
Although the expert analysts at FMI have revealed growth-propelling factors in the prevailing endoscope and disinfectants market, some aspects are also identified to inhibit the growth of the market. They are:
The healthcare policies such as Medicaid and Medicare have kept the costs associated with Healthcare-associated Infections (HAIs), including SSIs, out of coverage. Hence, the patients have to pay it out of their pocket, which is a major factor restricting the growth of the market.
Principal Consultant
North America is currently dominating the market and is projected to account for a total of 35.1% market share of endoscopes and disinfectants during the forecast period.
The USA is a leading country in North America, which is surging the market by collecting huge revenue in recent years. In addition to this, the demand for safe and effective surgical procedures has been rising in the US over the last few years, with over 15 million endoscopy procedures performed annually. This is propelling the endoscope detergents and disinfectants market size in the coming years.
Europe is projected to follow the North American region and hold a significant market share of 29.1% in the forum among all the regions during the forecast period.
Due to the rising numbers of healthcare infrastructure and the presence of rising patients and geriatric populations in the region, it is likely to impact the market in the long run for Europe. With increasing age, gastrointestinal (GI) related diseases increase. The endoscope is used in the diagnosis and treatment of GI-related diseases.
Let’s take a stroll across the dominating segments in the concerned forum:
| Segment | QuaternaryAmmonium Compounds (By Type) |
|---|---|
| Market Share in Base Year | 31.4% |
| Attributing Reasons | These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics |
| Segment | Medical Device Disinfectant (By Product) |
|---|---|
| Market Share in Base Year | 45.7% |
| Attributing Reasons | The increasing number of surgical procedures across the globe may be considered to be one of the major reasons for driving the segment over the forecast period. |
| Segment | Business to Business (By Sales Channel) |
|---|---|
| Market Share in Base Year | 65.1% |
| Attributing Reasons | Medical device disinfectants, enzymatic cleaners, and surface disinfectants are major antiseptics and disinfectants highly marketed under the B2B sales channel. |
| Segment | Hospital (By End-Use) |
|---|---|
| Market Share in Base Year | 46.2% |
| Attributing Reasons | The increasing incidence of hospital-acquired infections across the globe is one of the major reasons for segment growth over the forecast period. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The technology in medicine is popped out by the various clinical and Research and Development institutions. Nowadays, start-up companies are interested in making unique devices to help patients throughout their treatment and recovery. This is likely to increase the opportunities in the endoscope detergents market in recent years.
| Start-up Company | EnVision Endoscopy |
|---|---|
| Base Country and Year | US-based Start-up, 2018 |
| Developments | The start-up provides various clinical surgeries with innovative and effective solutions. They are developing endoscopic surgery devices to help patients to recover their health with minimal expense. However, the company is developing a low-cost IGSS (Image Guided Suturing System) for managing gastrointestinal defects. |
| Start-up Company | MiWendo |
|---|---|
| Base Country and Year | Spain-based Start-up, 2019 |
| Developments | The company is using microwave technology with a safe electromagnetic that is used to attach at conventional colonoscopy. Hence, it helps to detect polyps 360 Degrees and benign tissues |
The key players are focusing on the product, which hits consumers' desires. These players are adopting various methods to acquire a maximum share of the market, some of them are mergers, acquisitions, and product launches.
Recent Developments in the Endoscope Detergents and Disinfectants
The newly adopted robotic systems were introduced in telesurgery in recent years. The first of this surgery is called the Lindbergh operation, which is a more effective and innovative surgery.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Chemical Properties, Potency, End User, Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASIAN, GCC Countries, South Africa |
| Key Companies Profiled | MEDIVATORS Inc.; STERIS plc; Borer Chemie AG; Cantel Medical; Getinge AB; Olympus Corporation; Vesimin Health; MDD Company GmbH; Georg Pauldrach; SIRMAXO CHEMICALS PVT.LTD; Serim Research Corporation |
| Customization | Available Upon Request |
The endoscope detergents and disinfectants market is predicted to advance at a CAGR of 4.4% through 2032.
The North America is anticipated to lead the endoscope detergents and disinfectants market during the forecast period.
The endoscope detergents and disinfectants market is likely to hold a valuation of US$1,108.2 million by 2032.
Healthcare sector is the key driver in the endoscope detergents and disinfectants market.
1. Executive Summary | Endoscope Detergents And Disinfectants Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Chemical Properties
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Chemical Properties, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Chemical Properties, 2022 to 2032
5.3.1. Acidic
5.3.2. Neutral
5.3.3. Alkaline
5.3.4. Enzymatic
5.4. Y-o-Y Growth Trend Analysis By Chemical Properties, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Chemical Properties, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Potency
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Potency, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Potency, 2022 to 2032
6.3.1. Low-Level Disinfectants
6.3.2. Medium-Level Disinfectants
6.3.3. High-Level Disinfectants
6.4. Y-o-Y Growth Trend Analysis By Potency, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Potency, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Clinics
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. United States of America
9.2.1.2. Canada
9.2.2. By Chemical Properties
9.2.3. By Potency
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Chemical Properties
9.3.3. By Potency
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Chemical Properties
10.2.3. By Potency
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Chemical Properties
10.3.3. By Potency
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Chemical Properties
11.2.3. By Potency
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Chemical Properties
11.3.3. By Potency
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Malaysia
12.2.1.6. Singapore
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of APAC
12.2.2. By Chemical Properties
12.2.3. By Potency
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Chemical Properties
12.3.3. By Potency
12.3.4. By End User
12.4. Key Takeaways
13. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Chemical Properties
13.2.3. By Potency
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Chemical Properties
13.3.3. By Potency
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. United States of America
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Chemical Properties
14.1.2.2. By Potency
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Chemical Properties
14.2.2.2. By Potency
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Chemical Properties
14.3.2.2. By Potency
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Chemical Properties
14.4.2.2. By Potency
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Chemical Properties
14.5.2.2. By Potency
14.5.2.3. By End User
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Chemical Properties
14.6.2.2. By Potency
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Chemical Properties
14.7.2.2. By Potency
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Chemical Properties
14.8.2.2. By Potency
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Chemical Properties
14.9.2.2. By Potency
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Chemical Properties
14.10.2.2. By Potency
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Chemical Properties
14.11.2.2. By Potency
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Chemical Properties
14.12.2.2. By Potency
14.12.2.3. By End User
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Chemical Properties
14.13.2.2. By Potency
14.13.2.3. By End User
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Chemical Properties
14.14.2.2. By Potency
14.14.2.3. By End User
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Chemical Properties
14.15.2.2. By Potency
14.15.2.3. By End User
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Chemical Properties
14.16.2.2. By Potency
14.16.2.3. By End User
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Chemical Properties
14.17.2.2. By Potency
14.17.2.3. By End User
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Chemical Properties
14.18.2.2. By Potency
14.18.2.3. By End User
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Chemical Properties
14.19.2.2. By Potency
14.19.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Chemical Properties
15.3.3. By Potency
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. MEDIVATORS Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.4.1. Marketing Strategy
16.1.2. STERIS plc
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.4.1. Marketing Strategy
16.1.3. Borer Chemie AG
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.4.1. Marketing Strategy
16.1.4. Cantel Medical
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.4.1. Marketing Strategy
16.1.5. Getinge AB
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.4.1. Marketing Strategy
16.1.6. Olympus Corporation
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.4.1. Marketing Strategy
16.1.7. Vesimin Health
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.4.1. Marketing Strategy
16.1.8. MDD Company GmbH
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.4.1. Marketing Strategy
16.1.9. Georg Pauldrach
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.4.1. Marketing Strategy
16.1.10. SIRMAXO CHEMICALS PVT.LTD
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.4.1. Marketing Strategy
16.1.11. Serim Research Corporation
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.4.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Endoscope Detergents And Disinfectants Market
